Loading: 100%
Align Technology Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 6,060 (as per Q1 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker ALGNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17050100150200
datesClosing price (adj.)
13.10.2017192.81
11.10.2017192.46
04.10.2017185.98
27.09.2017184.78
20.09.2017188.78
13.09.2017183.57
06.09.2017176.63
30.08.2017174.88
23.08.2017172.85
16.08.2017178.46
09.08.2017175.77
02.08.2017167.99
26.07.2017158.69
19.07.2017159.28
12.07.2017152.51
05.07.2017151.94
27.06.2017149.34
20.06.2017146.99
13.06.2017144.38
06.06.2017148.62
30.05.2017143.33
23.05.2017138.22
16.05.2017138.61
09.05.2017138.17
02.05.2017134.12
25.04.2017118.78
18.04.2017116.32
11.04.2017114.95
04.04.2017115.61
28.03.2017113.90
21.03.2017111.06
14.03.2017107.48
07.03.2017103.15
28.02.2017102.76
21.02.2017101.86
14.02.201798.39
07.02.201793.65
31.01.201791.69
24.01.201791.65
17.01.201795.34
10.01.201796.13
03.01.201796.96
27.12.201698.66
19.12.2016100.25
12.12.201698.53
05.12.201694.01
28.11.201695.34
21.11.201696.18
14.11.201690.22
07.11.201687.86
31.10.201685.92
24.10.201689.26
17.10.201689.79
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
192.81n/a
Market Capitalisation
in million USD
15,489n/a
Enterprise Value
in million USD
14,943n/a
Common Shares Outstanding
as per Apr 28, 2017
80,331,340n/a
Preferred Shares Outstanding
as per Apr 28, 2017
n/a
Average Basic Shares Outstanding
TTM
79,874,250n/a
Average Diluted Shares Outstanding
TTM
1,663,250n/a
Index Membership
n/a
Business Summary
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 1,151n/a
Gross Profit 870n/a
Operating Income 257n/a
EBITDA 284n/a
Net Profit 219n/a
Balance Sheet
Cash and Cash Equivalents 546n/a
Receivables 267n/a
Total Current Assets 918n/a
PP&E 232n/a
Total Assets 1,459n/a
Accounts Payable 37n/a
Current Debt 0n/a
Total Current Liabilities 366n/a
Long-Term Debt 0n/a
Total Liabilities 414n/a
Total Equity 1,045n/a
Cash Flow
Depreciation & Amortisation 27n/a
Change in Working Capital -48n/a
Operating Cash Flow 265n/a
Net Change in PP&E and Intangibles -110n/a
Investing Cash Flow -37n/a
Dividends Paid 0n/a
Financing Cash Flow -119n/a
Total Change in Cash 107n/a
Free Cash Flow 95n/a
Profitability Ratios
Gross Margin 75.6%n/a
Operating Margin 22.3%n/a
Net Profit Margin 19.0%n/a
Return on Equity 20.9%n/a
Return on Assets 15.0%n/a
Per Share Figures
Basic EPS 2.74n/a
Diluted EPS 131.40n/a
Sales per Share 14.42n/a
Book Value per Share 13.08n/a
FCF per Share 1.19n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 70.47n/a
Price to Sales Ratio 13.37n/a
Price to Book Value 14.74n/a
Price to Free Cash Flow 162.68n/a
Valuation Metrics
EV/EBITDA 52.55n/a
EV/Sales 12.98n/a
Book to Market Value 0.07n/a
Other Ratios
Current Ratio 251.2%n/a
Liabilities to Equity Ratio 39.7%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
304
312
387
480
560
660
762
845
1,080
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-79
-79
-84
-118
-144
-162
-183
-205
-265
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
225
233
303
361
416
498
578
640
815
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-210
-198
-205
-271
-331
-404
-385
-451
-566
Selling, General & Administrative
-177
-174
-179
-234
-251
-293
-332
-390
-491
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-26
-22
-26
-37
-43
-44
-53
-61
-76
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
-6
-1
0
0
-37
-67
0
0
0
Operating Income (Loss)
16
36
99
90
86
94
194
189
249
Non-Operating Income (Loss)
2
0
-1
0
-1
-1
-3
-3
-6
Interest Expense, net
3
0
1
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
0
-1
0
-1
-1
-3
-3
-6
Pretax Income (Loss), Adjusted
17
36
98
90
84
93
190
186
243
Abnormal Gains (Losses)
0
-70
4
0
0
0
0
0
-2
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
17
-34
102
90
84
93
190
186
241
Income Tax (Expense) Benefit, net
63
3
-28
-23
-26
-29
-45
-42
-51
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
80
-31
74
67
59
64
146
144
190
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
80
-31
74
67
59
64
146
144
190
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
80
-31
74
67
59
64
146
144
190
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
80
-31
74
67
59
64
146
144
190
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
186
303
248
335
370
455
527
640
Cash & Cash Equivalents
n/a
166
295
241
306
243
200
168
389
Short Term Investments
n/a
20
9
7
28
127
255
360
251
Accounts & Notes Receivable
n/a
55
65
92
99
113
130
159
247
Accounts Receivable, Net
n/a
55
65
92
99
113
130
159
247
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
2
3
9
15
14
16
19
27
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
18
17
36
37
47
57
27
38
Prepaid Expenses
n/a
18
17
32
37
19
20
27
38
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
29
37
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
4
0
0
0
0
0
Total Current Assets
n/a
261
389
385
486
545
657
732
953
Property, Plant & Equipment, Net
n/a
25
31
54
79
76
90
136
175
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
9
0
21
102
148
151
105
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
69
49
210
170
110
93
139
163
Intangible Assets
n/a
5
2
50
46
85
82
79
0
Goodwill
n/a
0
0
135
99
0
0
0
82
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
62
42
22
22
16
3
51
68
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
2
3
3
3
9
8
8
13
Total Noncurrent Assets
n/a
94
88
264
271
287
331
427
443
Total Assets
n/a
355
477
649
756
832
988
1,159
1,396
Liabilities and owners' equity
Payables & Accruals
n/a
49 48944000
59 59126000
96 95865000
94 93796000
98 98063000
111 111127000
142 142119000
163 162928000
Accounts Payable
n/a
6 6122000
8 7768000
19 19265000
20 19549000
18 17718000
23 23247000
34 34354000
29 28596000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
43 42822000
51 51358000
77 76600000
74 74247000
80 80345000
88 87880000
108 107765000
134 134332000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
32 32299000
34 33848000
52 52252000
62 61975000
77 77275000
91 90684000
130 129553000
191 191407000
Deferred Revenue
n/a
32 32299000
34 33848000
52 52252000
62 61975000
77 77275000
91 90684000
130 129553000
191 191407000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
81 81243000
93 92974000
148 148117000
156 155771000
175 175338000
202 201811000
272 271672000
354 354335000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
1 961000
6 6222000
10 10366000
19 19224000
23 22839000
33 33415000
39 39035000
46 46427000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1 961000
6 6222000
10 10366000
19 19224000
23 22839000
33 33415000
39 39035000
46 46427000
Total Noncurrent Liabilities
n/a
1 961000
6 6222000
10 10366000
19 19224000
23 22839000
33 33415000
39 39035000
46 46427000
Total Liabilities
n/a
82 82204000
99 99196000
158 158483000
175 174995000
198 198177000
235 235226000
311 310707000
401 400762000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
525 525080000
556 555859000
607 607248000
671 670740000
730 729586000
783 783418000
822 821515000
865 864879000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-252 -252499000
-178 -178246000
-117 -116513000
-90 -89626000
-96 -95910000
-31 -30507000
27 27391000
131 131448000
Other Equity
n/a
0 455000
0 134000
0 46000
0 203000
0 294000
0 -140000
-1 -980000
-1 -938000
Equity Before Minority Interest
n/a
273 273036000
378 377747000
491 490781000
581 581317000
634 633970000
753 752771000
848 847926000
995 995389000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
273 273036000
378 377747000
491 490781000
581 581317000
634 633970000
753 752771000
848 847926000
995 995389000
Total Liabilities & Equity
n/a
355 355240000
477 476943000
649 649264000
756 756312000
832 832147000
988 987997000
1,159 1158633000
1,396 1396151000
Remarks restated on n/a restated on Feb 24, 2011 n/a restated on Feb 29, 2012 n/a restated on Mar 1, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 26, 2015 n/a restated on Feb 25, 2016 n/a restated on Feb 28, 2017 n/a restated on May 4, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
80
-31
74
67
59
64
146
144
190
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
13
13
14
17
18
17
18
18
24
Non-Cash Items
-46
77
30
16
63
65
54
55
51
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-7
16
11
30
-6
39
9
21
-17
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
40
74
130
130
134
186
227
238
248
Change in Fixed Assets & Intangibles
-14
-7
-18
-30
-38
-19
-24
-53
-71
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
13
6
2
10
-42
-181
-177
-113
198
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
-188
0
-8
0
0
-47
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
-4
2
-2
0
0
-8
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-1
-2
-16
-212
-78
-211
-202
-166
73
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-40
8
12
18
-5
-61
-80
-90
-82
Increase in Capital Stock
11
8
12
26
42
34
18
11
14
Decrease in Capital Stock
-50
0
0
-8
-47
-95
-98
-102
-96
Other Financing Activities
0
-1
3
9
15
23
14
-10
-13
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-40
7
15
27
10
-38
-66
-101
-96
Net Cash Before Disc. Operations and FX
-2
79
128
-54
66
-63
-41
-29
225
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-2
79
128
-54
66
-63
-41
-29
225
Effect of Foreign Exchange Rates
0
0
0
0
0
-1
-2
-3
-3
Net Changes in Cash
-2
79
128
-54
66
-63
-43
-32
222
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo